Axonal Kv1 channels regulate action potential propagation-an evolutionarily conserved function important for the control of motor behavior as evidenced from the linkage of human Kv1 channel mutations to myokymia/episodic ataxia type 1 (EA1) and the Shaker mutant phenotype in Drosophila. To search for the machinery that mediates axonal targeting of Kv1 channels composed of both a and b subunits, we first demonstrate that Kvb2 is responsible for targeting Kv1 channels to the axon. Next, we show that Kvb2 axonal targeting depends on its ability to associate with the microtubule (MT) plus-end tracking protein (+TIP) EB1. Not only do Kvb2 and EB1 move in unison down the axon, Brefeldin A-sensitive Kv1-containing vesicles can also be found at microtubule ends near the cell membrane. In addition, we found that Kvb2 associates with KIF3/kinesin II as well. Indeed, Kv1 channels rely on both KIF3/kinesin II and EB1 for their axonal targeting.
Introduction
Axonal voltage-gated potassium (Kv1, KCNA, Shaker) channels control action potential waveform and regulate the fidelity of action potential propagation (Chiu et al., 1999; Debanne, 2004; Hodgkin and Huxley, 1952) . Multiple Kv1 family members including Kv1.1, Kv1.2, and Kv1.4, which share w70% amino acid identity, give rise to Kv channels in mammalian axons with functions important for normal behavior and neuronal excitability (Chiu et al., 1999; Smart et al., 1998) . Indeed, mutations of the human KCNA1 gene cause episodic ataxia type 1 (Browne et al., 1994) , most likely due to abnormally robust action potential invasion of axonal branches of central neurons (Herson et al., 2003) , as well as hypokalemic myokymia-a likely consequence of action potential reflection (backfiring) from motor nerve terminals (Zhou et al., 1998) . Myokymic and neuromyotonic discharges of motor axons have also been associated with autoantibodies against Kv1 channels in patients with autoimmune, sometimes paraneoplastic, conditions (Lang and Vincent, 2003) . Intriguingly, Kv1 channel function is important not only for movement but also for sleep; Shaker flies are short sleepers (Cirelli et al., 2005) . To better understand the physiological function and regulation of Kv1 channels, it will be important to learn how these channels target to the axon.
In the mammalian brain, Kv1 channels reside in the axons and terminal fields in multiple brain regions (Monaghan et al., 2001; Southan and Robertson, 2000) and in cultured neurons (Grosse et al., 2000; Gu et al., 2003) . Their axonal targeting requires the highly conserved Kv1 T1 tetramerization domain. T1 mutations that disrupt T1-Kvb interaction abolish the ability of T1 to mediate axonal targeting (Gu et al., 2003) thus implicating Kvb, which belongs to the eldo-keto reductase family (Heinemann and Hoshi, 2006) . These Kvb subunits regulate Kv1 channel inactivation (Rettig et al., 1994) and promote channel forward trafficking (Shi et al., 1996) ; however, it is not known how Kvb might target Kv1 channels to the axon.
Microtubule (MT)-interacting proteins are good candidates for mediating axonal targeting, since MT extends down the axon with its plus end pointing distally (Heidemann et al., 1981) . A number of +TIPs including EB1 specifically track the rapidly growing MT plus end and concentrate in distal axons and growth cones Zhou et al., 2004) . Whether axonal targeting involves the association of cargos with +TIPs as well as kinesin, perhaps in a way analogous to protein targeting to the cell end in yeast , is an interesting open question.
Initially identified as a binding partner of the tumor suppressor adenomatous polyposis coli (APC; Su et al., 1995) , EB1 binds to MT plus end and promotes MT extension (Akhmanova and Hoogenraad, 2005) . The evolutionarily conserved EB1 contains an N-terminal calponin homology domain for MT binding (Hayashi and Ikura, 2003) and a C-terminal domain for dimerization and for interaction with EB1-binding proteins including other +TIPs such as APC (Hayashi et al., 2005; Honnappa et al., 2005; Slep et al., 2005) . EB1 can display plus-end accumulation in the absence of other +TIPs in yeast and in mammals (Akhmanova and Hoogenraad, 2005) . Moreover, EB1 may enhance kinesin interaction with microtubules (Browning and Hackney, 2005; Galjart, 2005) and help localizing kinesin to MT plus ends in yeast . Similarly, APC, which is transported along the microtubule via KIF3/kinesin II, may be anchored at the MT plus end by EB1 in mammalian cells (Akhmanova and Hoogenraad, 2005) .
How membrane proteins such as Kv1 channels are transported down the axon is an interesting open question. Whereas KIF3/kinesin II is involved in the axonal transport of 90-160 nm vesicles (Yamazaki et al., 1995) and w40% of these vesicles contain the KIF3-interacting protein fodrin (Takeda et al., 2000) , it is unknown how most of the cargo vesicles are recognized by KIF3, nor have the molecular contents of these vesicles been *Correspondence: lily.jan@ucsf.edu (L.Y.J.), gu.49@osu.edu (C.G.)
identified. There is also no precedent for the involvement of EB1 in axonal targeting of membrane proteins.
In this study, we first showed that axonal targeting of YFP-Kvb2 was independent of its ability to interact with Kv1 a subunits, and then identified a novel interaction between Kvb2 and EB1. Fluorescence resonance energy transfer (FRET) and live-cell imaging studies further revealed that Kvb2 and EB1 closely associated with each other as they moved together anterogradely along the axon. We also identified KIF3/kinesin II as the microtubule-based motor that associates with Kvb2. Finally, reduction of endogenous EB1 or KIF3 blocked axonal targeting of Kv1 channels but not voltage-gated sodium (Nav) channels.
Results

Distribution of Endogenous Kvb2 in Axons
Kvb2 is likely responsible for axonal targeting of Kv1 channels, because mutant T1 domains that cannot bind Kvb2 (CD4-S40W) could not target the reporter protein CD4 to hippocampal neuronal axons (see Figure S1A in the Supplemental Data available with this article online; Gu et al., 2003) , and Kvb2 appeared at 4 DIV (days in vitro), before Kv1 channel a subunits could be detected. Consistent with the reported expression pattern in hippocampal slices (Monaghan et al., 2001) , Kvb2 was present in both axonal and somatodendritic regions at 7 DIV ( Figures 1A-1C ) and accumulated at the axonal growth cones ( Figure 1A ).
Axonal Targeting of YFP-Kvb2 Depends on Microtubule Dynamics
Similar to endogenous Kvb2, YFP-Kvb2 was found in axons, especially in distal axons, as well as in the somatodendritic region albeit at a lower level ( Figure 1H ). Treatment of neurons for 36 hr with the actin depolymerizing agent Latrunculin A (200 nM) or the actin stabilizing compound Jasplakinolide (5 nM) did not affect axonal targeting of YFP-Kvb2 ( Figure 1E ). Because prolonged exposure of neurons to nocodazole seriously compromised neuronal survival and axonal morphology, it was only possible to examine neurons treated with 100 nM nocodazole, which had no significant effect ( Figure 1E ). This low dose of nocodazole may affect microtubule dynamics (Mimori-Kiyosue et al., 2000) ; however, in different cell types, this treatment could either increase or decrease MT catastrophe frequency (Vasquez et al., 1997) . Interestingly, treatment with 10 nM or 20 nM paclitaxel, the chemotherapeutic agent that stabilizes microtubule (Rouzier et al., 2005; Tirnauer and Bierer, 2000) , significantly reduced axonal targeting of Kvb2 ( Figures  1D and 1E ) but not CFP-VAMP2 ( Figure S1B ), suggesting that dynamic microtubule growth is important for targeting Kvb2 to the axon.
The Critical Role of Kvb2 in Kv1 Channel Axonal Targeting
To ask whether Kvb2 can target to the axon independent of its association with the T1 domain of Kv1 a subunits, we introduced two mutations at the Kvb2-T1 interface ( Figure 1G ); K235E but not M196A abolished Kvb2 association with T1, while both Kvb2 mutants exhibited normal axonal targeting ( Figures 1F-1I and data not shown). The inability of YFP-Kvb2 K235E (YFP-K235E) to interact with CFP-Kv1.2 was evident from live-cell FRET imaging of HEK293 cells. Whereas wild-type YFP-Kvb2 colocalized and closely associated with CFP-Kv1.2 on the cell membrane as revealed by the strong FRET signals ( Figure 2B ), indicating that they are within 5 nm of each other (Figure 2A ), no FRET signal was detected between CFP-Kv1.2 and YFP-K235E ( Figure 2C ). The inability of CFP-Kv1.2 to interact with the mutant Kvb2 also prevented surface expression ( Figure 2C ). Taken together, normal axonal targeting of this Kvb2 mutant ( Figures  1F-1I ), as well as the early appearance of Kvb2 in hippocampal axons ( Figure 1A ), supports the notion that Kvb2 can independently target to the axon.
Next, we tested the effects of expressing YFP, YFPKvb2, or YFP-K235E on axonal surface expression of The API of each condition is given in mean and standard error. The APIs of Kv1.2HA in the presence of YFP were control levels indicated by black (surface) and gray (total) lines. Student's t test and one-way ANOVA were performed for comparing surface and total API, respectively. Black and gray asterisks indicate the difference from control is statistically significant. Since YFP-K235E totally blocked Kv1.2HA surface targeting in both dendrites and axons, we set its axonal surface polarity index at 0. More than 20 neurons were measured for each condition.
Kv1.2 with an extracellular HA tag (Kv1.2HA). To quantify the polarized expression, we determined the axonal polarity index (API), the ratio of average immunofluorescence intensity for major axonal versus dendritic branches, for both surface expression (surface API) and total Kv1.2HA protein level (total API). While in YFP-expressing neurons Kv1.2HA can be sorted to axon and axonal surface (surface API, 2.47 6 0.24, n = 32; total API, 0.89 6 0.08, n = 25; Figures 2D and 2H)-probably due to the low level of endogenous Kvb2 present, overexpression of YFP-Kvb2 dramatically enhanced Kv1.2HA axonal targeting (surface API, 4.17 6 0.5, n = 41, p < 0.001; total API, 1.78 6 0.15, n = 27, p < 0.01; Figures 2E and 2H) . Moreover, whereas axonal targeting of YFP-Kvb2 was observed in about threequarters of the neurons ( Figure 1F ), YFP-Kvb2 Y90A was enriched in the axons of fewer than 20% of the neurons examined (14.2% 6 2.4%, n = 4, p < 0.0001). Thus, most likely Kvb2 Y90A competes with endogenous Kvb2 for Kv1 binding, thereby interfering with Kv1 channel axonal targeting (Campomanes et al., 2002) . Expression of YFP-K235E also had dominant-negative effects on Kv1.2HA axonal targeting (surface API, 0, n = 33; total API, 0.24 6 0.05, n = 20, p < 0.01; Figures 2F-2H ). Since this Kvb2 mutant could not interact with Kv1.2 ( Figure 2C ) and yet showed normal axonal targeting on its own (Figures 1F and 1I) Figures 1D and 1E ), compromises MT association with EB1 (Morrison et al., 1998; Tirnauer and Bierer, 2000) , we tested whether Kvb2 is associated with EB1. Indeed, we detected EB1 in the complexes brought down by antiKvb2 and anti-Kv1.2 antibodies from rat brain lysates in our in vivo coimmunoprecipitation (CoIP) experiments ( Figure 3A ), revealing that endogenous EB1 is associated with complexes containing Kv1 channels in the rat brain. This could reflect either a direct association between EB1 and Kvb2 or may rather reflect an indirect association of these proteins via other proteins in the complex. To test whether EB1 and Kvb2 can associate with one another directly, we turned to GST-pull-down assays and heterologous expression systems. Bacterially expressed HIS-EB1 brought down Kvb2 expressed in HEK293 cells ( Figure 3B ), and bacterially expressed GST-Kvb2 brought down EB1 from rat brain lysates ( Figure 9A ). In addition, when coexpressed in the yeast Pichia pastoris, mammalian Kvb2 and EB1 were associated with each other ( Figure S2 ). The interaction was further confirmed in CoIP studies using HEK293 cells transfected with Kvb2 together with EB1-GFP (Figure 3D ). These experiments thus reveal a novel interaction between Kvb2 and EB1, likely due to their direct physical association.
To identify the domain of EB1 that associates with Kvb2, we fused YFP to either the N-or the C-terminal domain of EB1, to generate YFP-EB1N and YFP-EB1C ( Figure 3C ) and found that YFP-EB1C but not YFP-EB1N coimmunoprecipitated with Kvb2 coexpressed in HEK293 cells ( Figure 3E ). The EB1N containing the MTbinding domain (Hayashi and Ikura, 2003 ) is connected via a flexible linker to the EB1C domain that exhibited association with Kvb2 as well as other +TIPs. Given that duplication of binding sites due to EB1 dimerization provides the scaffold for forming macromolecular +TIP complexes (Hayashi et al., 2005; Honnappa et al., 2005; Slep et al., 2005) , we next explored the potential of EB1 association for MT plus end-directed transport of Kv1 channels to the axon.
Distribution of EB1 and Kv1.2/Kvb2 in Neuronal Soma and Axons EB1 expression was already substantial at 3 DIV, with prominent enrichment at the axonal endings (data not shown). At 7 DIV, EB1 appeared as punctate structures in axons; its level in distal axons was twice the level in proximal axons and dendrites ( Figures 3F-3I ). Cometlike EB1 immunoreactivity could also be seen in neurons and glial cells in the same culture ( Figure S3 ). Our observations are in agreement with previous studies suggesting that microtubules exhibit dynamic growth all along the axon Stepanova et al., 2003) .
Next, we carried out double labeling of EB1 and Kv1.2 in hippocampal neurons. At 14 DIV, when Kv1.2 just became detectable (Grosse et al., 2000; Gu et al., 2003) , EB1 and Kv1.2 partially colocalized in soma and large axonal endings ( Figure 4A ); there are also punctate structures positive for Kv1.2 but not EB1, which could be Kv1.2-containing vesicles that have reached their docking sites near the axonal membrane, and ones positive for EB1 but not Kv1.2, and possibly some low level of Kv1.2 immunoreactivity on the axonal membrane in neurons at 14 DIV and 21 DIV ( Figures 4A and S4 ). The Kv1.2-containing puncta showing partial colocalization with EB1 (Figures 4B and 4C) were sensitive to Brefeldin A treatment ( Figure 4A ) and hence likely post-Golgi carrier vesicles. Total internal reflection fluorescence (TIRF) imaging further revealed some of those Kv1.2-containing puncta at the MT ends near the cell membrane ( Figure 4D ). Similarly, transfected fibroblasts in the hippocampal neuronal culture also exhibited MT association of YFP-Kvb2 and YFP-Kv1.2 near the cell periphery ( Figures S5A and S5B ).
Since Kv1 and Kvb coassemble before the a 4 b 4 channels exit the endoplasmic reticulum (Shi et al., 1996) , those Kv1.2-containing structures that colocalize with EB1 and are Brefeldin A-sensitive most likely contain Kvb. Given that the Kvb2 and EB1 antibodies are both of mouse origin, we verified their partial colocalization by observing an overlap between EB1-GFP or YFPKvb2 and immunofluorescence for endogenous Kvb2 or EB1, respectively ( Figures S5C and S5D ).
Kvb2 Mutants with Weakened EB1 Association and Impaired Axonal Targeting Next, we tested Kvb2 truncation mutations ( Figure 5A ) for EB1 association and axonal targeting. Deleting the last 14 residues (YFP-Kvb2C1) did not affect EB1 interaction in CoIP assays ( Figure 5B ) or axonal targeting of this truncated Kvb2 ( Figure 5C ). Further deletion of an additional 15 residues (YFP-Kvb2C2), however, dramatically decreased EB1 association ( Figure 5B ) as well as axonal targeting ( Figure 5C ). Moreover, deletion of 90 residues from the N terminus of Kvb2, which is in the vicinity of the Kvb2 C terminus structurally (Gulbis et al., 1999) , also disrupted both EB1 association and axonal targeting ( Figures 5B and 5C ).
Visualizing the Interaction of Kvb2 and EB1 in Axons
Using FRET imaging of cultured hippocampal neurons expressing EB1-YFP and CFP-Kvb2, we found that these fluorescent fusion proteins were not only both targeted to distal axons ( Figure 6A ), there was strong fluorescence resonance energy transfer from CFP-Kvb2 to EB1-YFP in axons ( Figure 6C ), axonal branches, and endings (data not shown). Only a small fraction of these neurons exhibited FRET signals in their soma ( Figure 6E ).
As control, we examined hippocampal neurons expressing CFP-Kvb2 and YFP-EB1N, the MT binding domain that did not associate with Kvb2, and observed no detectable FRET signals ( Figure S6 ).
Expression of EB1 C-Terminal Domain Interfered with Axonal Targeting of CFP-Kvb2
Unlike YFP-EB1, YFP fused to the EB1 C-terminal domain, YFP-EB1C, had dominant-negative effects on axonal targeting of CFP-Kvb2 ( Figure 6B ), though they displayed robust FRET signals in the soma ( Figure 6F ). In the rare cases of neurons with barely detectable axonal CFP-Kvb2, very weak FRET signals could only be detected in the proximal axons ( Figure 6D ). This dominant-negative effect appeared specific for Kvb2, because YFP-EB1C expression did not impair axonal (E) CoIP from transfected HEK293 cells revealed that Kvb2 interacts with the C-terminal region of EB1. Anti-GFP antibody was used in pull-down. Top panel, the IP blot probed with anti-Kvb2. Four percent of the inputs for IP were loaded (middle and lower panels). Molecular size is indicated on the left of the blots in kDa. Asterisks, bands corresponding to full-length GFP or fusion constructs. (F) Endogenous EB1 preferentially localizes to distal axons. Cultured hippocampal neurons at 7 DIV were costained with monoclonal anti-EB1 (in green) and polyclonal anti-MAP2 (in red) antibodies. (G) The camera lucida drawing of the neurons in (F) with dendrites in red and axons in blue. Quantification of EB1 immunofluorescence along 16 thick segments, marked with numbers, is shown in (H) (mean and standard deviation). The fluorescence intensity for each of these two axons and two dendrites is shown in (I), against the distance from the neuronal soma. Scale bar, 100 mm.
targeting of CFP-VAMP2 ( Figure S7A ) or the microtubule-associated protein Tau1 (Figure S7B ), though the axons of neurons expressing YFP-EB1C were shortened by approximately 50% (Figures S7C and S7D ), similar to the reported effect on dorsal root ganglion neurons with disrupted EB1 function (Zhou et al., 2004 ). (in red) shown in low magnification (top panels), in high magnification for axon ending and soma (middle panels), and for soma after Brefeldin A treatment (bottom panels). Kv1.2 and EB1 colocalized in axonal endings and in neuronal soma with double-labeled puncta (enlarged insets), which disappeared after exposing neurons to 5 mg/ml Brefeldin A for 4 hr before fixation and staining. (B) Kv1.2 and Kvb2 also colocalized in similar puncta in soma (enlarged insets). (C) Of the Kv1.2 positive dots, about half are also positive for EB1 (left; 50.7% 6 3.8%) or Kvb2 (right; 61.2% 6 4.0%). The number of neurons analyzed is given in white color. YFP-EB1C Exerts Dominant-Negative Effects on Kv1.2 Targeting to Axonal Surface Anti-HA antibody staining of unpermeabilized or permeabilized neurons expressing Kv1.2HA and Kvb2 together with YFP-EB1C, YFP-EB1N, or EB1-YFP revealed normal polarized Kv1.2HA expression in neurons expressing EB1-YFP (surface API, 2.70 6 0.25, n = 31; total API, 1.46 6 0.18, n = 24; Figures 7A and 7D) or YFP-EB1N (surface API, 2.20 6 0.3, n = 28, p > 0.05; total API, 1.31 6 0.11, n = 22, p > 0.05; Figures 7B and 7D ), but not YFP-EB1C (surface API, 0.40 6 0.11, n = 35, p < 0.01; total API, 0.39 6 0.10, n = 20, p < 0.01; Figures 7C and 7D) . The ability of Kv1.2HA to appear on the somatodendritic but not axonal membranes of most neurons expressing YFP-EB1C ( Figure 7C ) is consistent with the notion that Kvb2 is essential for Kv1 channel surface expression, whereas Kvb2 interaction with EB1 mediates Kv1 channel axonal targeting.
Suppressing Endogenous EB1 Level Impairs Kv1
Channel Axonal Targeting Next, we used a vector-based siRNA strategy to suppress endogenous EB1 level ( Figures 8A, 8B , and S8). EB1 knockdown impaired axonal targeting of overexpressed Kvb2 ( Figure 8C ) as well as endogenous Kvb2 ( Figure 8D ), but not Nav channels ( Figure 8F ) or Tau1 (Figures 8G and 8H) . Moreover, Kv1.1 antibody staining of neurons 5 days after transfection with EB1 siRNA (equivalent to 9 DIV) revealed that the endogenous Kv1.1 level in axons was greatly reduced (Figures 8E and 8H ).
EB1-YFP and CFP-Kvb2 Move in Unison along the Axon Two-color live-cell imaging further revealed that EB1-YFP and CFP-Kvb2 colocalized in puncta of different sizes. Whereas the large puncta tended to be stationary, the small puncta containing both EB1-YFP and CFPKvb2 moved toward the distal end of the axon ( Figure S9 ). These mobile particles were not uniform in size, generally less than 1 mm, and they usually moved for a few micrometers, resembling the EB1 short dashes observed in cell lines and neurons Stepanova et al., 2003;  Figure S9 ; Movies S1 and S2). For each neuron we imaged, we manually traced the forward movement of individual CFP/YFP double-positive particles and obtained the average velocity at room temperature (0.11 6 0.05 mm/s, n = 85), in the same range as EB1 tracking velocity.
Involvement of KIF3 in Kv1 Channel Axonal Targeting
Compared to the conventional kinesin KIF5/kinesin I, KIF3/kinesin II moves more slowly (w0.4 mm/sec) and less processively (average distance of translocation w4.5 mm; Berezuk and Schroer, 2004) . We found that KIF3/kinesin II is also involved in axonal targeting of Kv1 channels: first, bacterially expressed GST-Kvb2 pulled down from rat brain lysates not only EB1 but also KIF3 (Hirokawa and Takemura, 2005;  Figure 9A ). Second, when coexpressed in HEK293 cells, Kvb2 coimmunoprecipitated with KIF3A-GFP, but not KIF5B-GFP ( Figure 9B ). Third, endogenous KIF3A was at high levels in hippocampal neuronal soma, distal axons, and axonal endings, where it colocalized with EB1 and Kvb2 (Figure 9C) . Finally, we employed siRNA knockdown of endogenous KIF3A ( Figure S10 ). When transfected into neuron at 6 DIV, KIF3 siRNA impaired the axonal targeting of endogenous Kv1.2 ( Figures 9D and 9F ) but not Nav ( Figures 9E and 9F ) at 17 DIV. Thus, KIF3/kinesin II is also required for axonal targeting of Kv1 channels.
Discussion
Axonal Kv1 channels of the Shaker family regulate action potential propagation (Baccus et al., 2000; Chiu et al., 1999; Debanne, 2004; Hodgkin and Huxley, 1952) , a function important for normal behavior in flies, mice, and humans (Browne et al., 1994; Herson et al., 2003; Jan et al., 1977; Smart et al., 1998) . It is therefore of great interest to understand how Kv1 channels target to the axon.
In this study, we show that Kvb is the Kv1 channel subunit primarily responsible for axonal targeting. We further identify EB1, the +TIP that binds microtubule via its N-terminal domain and several other +TIPs via its C-terminal domain (Hayashi et al., 2005; Honnappa et al., 2005; Slep et al., 2005) , as a Kvb2 binding partner crucial for the axonal transport of Kv1 channels. Finally, we show that KIF3/kinesin II also associates with Kvb2 and is required for Kv1 channel axonal targeting:
Kvb2 Is Responsible for Kv1 Channel Axonal Targeting Axonal targeting of Kv1 channels likely entails physical interaction between Kv1 channel subunits and the axonal targeting machinery. We have previously shown that, when T1 is fused with single span membrane proteins such as CD4 and transferrin receptor, its ability to promote axonal targeting is abolished by mutations that prevents its binding to Kvb2 (Gu et al., 2003 ; Figure S1A ). Together with the finding of Kvb mutations disrupting Kv1 targeting to axons (Campomanes et al., 2002) , these studies raise the possibility that Kvb subunits are responsible for Kv1 channel axonal targeting.
Having found endogenous Kvb2 in the axons of cultured hippocampal neurons within the first week in vitro ( Figures 1A-1C) , we next showed that the K235E mutation of Kvb2 at the T1-Kvb2 interface ( Figure 1G ) eliminated T1 binding ( Figure 2C ) but did not affect axonal targeting ( Figures 1F-1I and 2F-2H ). Whereas YFPKvb2 expression enhanced targeting of Kv1.2HA to the axonal membrane ( Figures 2E and 2H) , expression of the YFP-K235E mutant incapable of assembling with Kv1.2 ( Figure 2C ) nearly eliminated the surface expression as well as axonal targeting of Kv1.2HA (Figures 2F-2H ). Taken together, these findings suggest that Kvb2 is responsible for targeting Kv1 channels to the axon.
The Microtubule Plus-End Tracking Protein EB1 Is Crucial for Kv1 Channel Axonal Targeting
To look for molecules involved in Kv1 channel axonal targeting, we began by identifying proteins in complex with Kvb2 in the rat brain. Following up our finding that YFP-Kvb2 axonal targeting was hampered by paclitaxel ( Figures 1D and 1E) , the microtubule stabilizing agent that also causes EB1 dissociation from microtubules (Morrison et al., 1998; Tirnauer and Bierer, 2000) , we Cultured hippocampal neurons were cotransfected at 6 DIV, with Kv1.2HA and Kvb2 plus either EB1-YFP (A), YFP-EB1N (B), or YFP-EB1C (C), then fixed and stained with anti-HA antibody in unpermeabilized condition. YFP fluorescence from these EB1-fusion constructs is shown in green in the left column. HA staining revealing the surface Kv1.2HA level is shown in red in the middle column. The lower panels are the staining of representative axonal segments enlarged four times from the upper panels. Scale bars, 100 mm. Arrows, axons. Arrowheads, dendrites. (D) Axonal polarity index of surface and total Kv1.2HA was reduced by coexpressed YFP-EB1C. Hippocampal neurons were cotransfected with Kv1.2HA and Kvb2, together with EB1-YFP, YFP-EB1N, or YFP-EB1C, then fixed and stained with anti-HA antibody in either nonpermeabilized (surface, close bars, black line, and asterisk) and permeabilized (total, open bars, gray line and asterisk) conditions. The API of each transfected neuron, the average anti-HA fluorescence intensity in axons normalized by that in dendrites (F axon /F dendrite ), was determined in more than 20 neurons for each combination in each of five independent transfections experiments. The mean and standard error of API were obtained for each condition, revealing statistically significant effects of YFP-EB1C on surface and total API of Kv1.2 (p < 0.01, one-way ANOVA followed by Dunnett's test).
found in CoIP studies association of EB1 with Kv1.2 and Kvb2 in the rat brain ( Figure 3A) and interaction of mammalian EB1 and Kvb2 expressed in the yeast Pichia (Figure S2) . Moreover, bacterially expressed His-EB1 pulled down Kvb2 ( Figure 3B ) and bacterially expressed GSTKvb2 pulled down EB1 ( Figure 9A ). In addition, Kv1.2 partially colocalized with EB1 in axons of hippocampal neurons ( Figures 4A and 4C) . These Kv1.2-containing Figure 8 . Suppressing Endogenous EB1 Level by siRNA Specifically Impaired Kv1 Channel Axonal Targeting (A) EB1 siR2 construct can efficiently suppress the expression of GFP-tagged EB1 in HEK293 cells. HEK293 cells were cotransfected with EB1-GFP plus control siR, EB1 siR1, or EB1 siR2 in 1:2 cDNA ratio. Three days later, cell lysates were resolved and blotted with anti-EB1, anti-a-tubulin, and anti-actin antibodies. (B) EB1 siR2 suppressed endogenous EB1 level in rat hippocampal neurons. Neurons transfected with control siR (upper panels) or EB1 siR2 (lower panels) were compared at low (top panel) and high magnification (bottom panel). GFP fluorescence (in green) is only present in the transfected neurons, while anti-EB1 staining (in red) shows the endogenous EB1 of all neurons in the field. (C) EB1 siR2 blocks axonal targeting of overexpressed Kvb2. Kvb2 together with either control siR or EB1 siR2 were cotransfected into hippocampal neurons. GFP fluorescence (in green) marks the transfected neurons. Anti-Kvb2 staining (in red) is mainly in axons and soma in control siR-transfected neurons (upper panels) but is restricted in somatodendritic regions in EB1 siR2-transfected neurons (lower panels). EB1 siR2 also dramatically suppressed the axonal staining level of endogenous Kvb2 (red in [D] ) and Kv1.1 (red in [E] ), but did not significantly affect axonal staining level of endogenous Nav channels (red in [F] ) and Tau1 (red in [G] ). (H) Effects of suppressing EB1 level on axonal targeting of different proteins. For each transfection, more than 20 GFP-positive neurons were imaged. The percentage of neurons with levels of staining in axons similar to those of control neurons was obtained from three independent transfections with either control siRNA (black bars) or EB1 siRNA2 (white bars) and is given as means and standard errors. Asterisks indicate significant differences (p < 0.001). Arrows, axons or axonal endings. Scale bars, 20 mm in (B), (C), and (F) and 10 mm in (D), (E), and (G). puncta, likely post-Golgi carrier vesicles given their sensitivity to Brefeldin A ( Figure 4A ), could be found at the MT ends near the cell membrane of neuronal soma ( Figure 4D ), as expected from their partial colocalization with EB1. Given the ability of EB1 to track the plus ends of growing microtubules while they extend distally in the axons Nakata and Hirokawa, 2003; Stepanova et al., 2003) , its association with Kv1 channel subunits in central neurons raises the intriguing question concerning the role of EB1 in Kv1 channel axonal targeting.
We have obtained several lines of evidence implicating EB1 in axonal targeting of Kv1 channels. First, there was excellent correlation between the ability of truncation mutants of Kvb2 to associate with EB1 and their axonal targeting (Figures 5A-5C ). Second, expression of a fluorescent fusion protein of EB1 C-terminal domain (YFP-EB1C) had dominant-negative effects over Kv1 channel axonal targeting (Figures 6 and 7 ). Finally, suppressing EB1 level via siRNA impaired the axonal targeting of endogenous Kv1.1/Kvb2 ( Figures 8D and 8E ), but not Nav channels and Tau1 ( Figures 8F-8H ). Taken together, these findings strongly suggest that EB1 is crucial for Kv1 channel axonal targeting. In future studies, it would be of interest to find out whether other +TIPs are involved in axonal targeting of Kv1 or other ion channels.
A Hypothesis for How EB1 and KIF3/Kinesin II Mediate Kv1 Channel Axonal Targeting How might axonal targeting of Kv1 channels be dependent on EB1? After assembly of Kv1.2 and Kvb2 in the endoplasmic reticulum (Misonou and Trimmer, 2004) , both endogenous channel subunits colocalize in puncta ( Figures 4B and 4C ) much the same way as Kv1.2 localization to the EB1-positive puncta ( Figures 4A and 4C) , presumably due to the association of EB1 with complexes of Kv1.2/Kvb2 in post-Golgi carrier vesicles. Our finding thus lends further support to the notion that the punctate distribution of endogenous EB1 could reflect EB1 association with vesicles or large protein complexes (Vaughan, 2005) . Whereas our two-color live-cell imaging showed anterograde comigration of Kvb2 and EB1 along axons ( Figure S9A ), at the rate of 0.11 6 0.05 mm/s at room temperature, reasonably comparable to the rate of EB1-GFP movement (w0.2 mm/s at 37 C; Stepanova et al., 2003) , it is important to note that the involvement of EB1 in Kv1 channel axonal targeting does not preclude a likely role of MT-based motors in axonal transport of Kv1 channels or the involvement of other +TIPs. Indeed, we have found interactions between Kvb2 and KIF3/kinesin II and a requirement of KIF3 for axonal targeting of endogenous Kv1 channels but not Nav channels (Figures 9 and S10) .
How could Kv1 channel axonal targeting be dependent on both EB1 and KIF3/kinesin II? Our findings indicate that the KIF3/kinesin II motor coimmunoprecipitated with Kvb2, suggesting that KIF3 either interacts Figure 9 . KIF3A Is Required for Kv1 Channel Axonal Targeting (A) Both KIF3A and EB1 from rat brain can be pulled down by purified GST-Kvb2. GST-Kvb2 was expressed in E. coli, purified with glutathione beads (lower panel), and then incubated with rat brain lysates. The elution was resolved and blotted with anti-KIF3A (upper panels) and anti-EB1 antibodies (middle panels). GST was the negative control. Five percent of input was loaded for comparison. (B) KIF3A-GFP but not KIF5B-GFP coimmunoprecipitated Kvb2. Upper panels are the diagrams of KIF3A-GFP and KIF5B-GFP constructs. KIF3A-GFP and Kvb2 (left), KIF5B-GFP and Kvb2 (middle), or EB1-GFP and Kvb2 (right) were coexpressed in HEK293 cells. The CoIP assay was performed using anti-GFP antibody; the blot was probed with anti-Kvb2 antibody (upper panel). Four percent of inputs were loaded (lower panel). (C) Endogenous KIF3A colocalizes with EB1 and Kvb2 in axons. Insets show the axonal ending of another neuron in high magnification. (D) Suppressing KIF3A with siRNA impairs Kv1.2 axonal targeting. Neurons transfected with either control siR plasmid (upper panels) or KIF3A siR2 plasmid (lower panels) together with GFP at 6 DIV, were stained for endogenous Kv1.2 at 17 DIV. (E) KIF3A knockdown did not alter Nav channel axonal targeting. Immunocytochemical signals are inverted, showing similar Nav channel targeting to axons (arrows) in control (top) and KIF3A siRNA (bottom) at 16 DIV. (F) For each siRNA transfection experiment, more than 20 GFP-positive neurons were imaged. The percentage of neurons with levels of staining in axons similar to those in control neurons was obtained from three independent transfections with either control siRNA (black bars) or KIF3A siRNA2 (white bars) and is given as means and standard errors for Kv1.2 (left) and Nav (right) channels. Asterisks indicate significant differences (p < 0.001). Arrows and arrowheads, axons. Scale bars, 100 mm in (C), 60 mm in (D) and (E), and 10 mm in (C) insets. directly with Kvb2 or at least that the two proteins are associated in a complex and that KIF3 is required for targeting of Kv1.2. Given that a vesicle may contain multiple Kv1 channels each of which containing four Kvb2 subunits, the same vesicle may be associated with both EB1 and KIF3, which moves at about twice the rate of EB1 tracking at the plus end of microtubules Nakata and Hirokawa, 2003; Stepanova et al., 2003) . Given the presence of bundles of microtubules with their growing plus ends pointing distally but distributed all along the axon, interaction between Kvb2 and EB1 as well as KIF3 may enhance the ability of Kv1-containing vesicles to stay associated with microtubules-with ends of microtubule presumably via EB1 ( Figure 4D ) and with microtubules via the KIF3 motor. The ability of Kvb2 subunits of the Kv1 channel to associate with the dimeric EB1 and the trimeric KIF3, which contains two motor proteins KIF3A and KIF3B, may further enhance the interaction between these proteins and microtubules, analogous to the ability of the yeast EB1 and kinesin-both dimeric proteins that associate with each other-to mutually stabilize their interactions with microtubules (Browning and Hackney, 2005; Galjart, 2005) , and the ability of EB1 and EB3 to mediate CLIP protein accumulation at the MT tips (Komarova et al., 2005) . In addition, as the KIF3-driven vesicle containing Kv1 channels reaches the MT plus end, its association with EB1, which promotes MT extension, may either allow the vesicle to hold onto the microtubule plus end before shifting to another microtubule in the bundle or-if the MT plus end is within reach of the axonal membrane, to facilitate vesicle delivery to the axonal membrane.
Interaction between the Evolutionarily Conserved EB1, Kvb, and KIF3/kinesin II Provides a Novel Mechanism for Axonal Targeting Kvb and its interacting proteins EB1 and KIF3/kinesin II are evolutionarily conserved; human EB1 when introduced to Xenopus egg extracts promotes MT extension and decreases catastrophe rates (Tirnauer et al., 2002) , and it partially rescues the loss-of-function phenotype for the fission yeast homolog of EB1 (Browning et al., 2003) . Given that in Drosophila melanogaster the hypomorphic DmEB1 mutants show neuromuscular defects, including uncoordinated movements and inability to fly , it would be of great interest to further determine whether the Kvb/EB1 interaction is evolutionarily conserved and whether kinesin II is required for Kv1 channel axonal targeting in both vertebrates and invertebrates.
In both central and peripheral nervous system, Kv1 channels are targeted to discrete domains of myelinated axons, the juxtaparanodal regions (Rhodes et al., 1997) . Given the important role of Kv1 channels in regulating axonal conduction of action potentials (Chiu et al., 1999; Debanne, 2004; Herson et al., 2003; Hodgkin and Huxley, 1952) , understanding the molecular mechanism underlying axonal targeting of these channel proteins not only will help us appreciate how Kv1 channel density in various regions of the axonal membrane could be modulated, it could also prove valuable to efforts aimed at designing treatments of axon demyelination and degeneration diseases, such as multiple sclerosis.
Experimental Procedures Materials
Reagents used include rabbit anti-MAP2 and anti-Tau1 antibodies (Chemicon), Phalliodin Alexa 680 (Molecular Probes), rat monoclonal anti-HA antibody (Roche), rabbit anti-EGFP antibody (a kind gift from Dr. Yang Hong), mouse anti-Kvb2, anti-Kv1.1, anti-Kv1.2 (Upstate Biotechnology and Antibodies Inc.), rabbit anti-Kv1.2 antibody (Alomone labs), mouse anti-EB1 antibody (BD Transduction Laboratories), rabbit anti-pan-Nav channel antibody (a kind gift from Dr. S. Rock Levinson), mouse anti-a-tubulin, anti-a-actin, and anti-panNav channel antibodies (Sigma), rabbit anti-KIF3A antibody (Abcam), Cy2, Cy3, and Cy5 conjugated secondary antibodies (Jackson Laboratory), Latrunculin A, Jasplakinolide, and Brefeldin A (Calbiochem), Nocodazole and Paclitaxel (Sigma), EB1-GFP (a kind gift from Dr. Michelle Piehl), VAMP2 (a kind gift from Dr. Richard Scheller), KIF5B (a kind gift from Dr. Ron Vale), and KIF3A (Invitrogen).
cDNA Constructs YFP-Kvb2 and CFP-Kvb2 were constructed by inserting the coding sequence of Kvb2 into pEYFP-C1 or pECFP-C1 (Clontech) between EcoRI and SalI sites. CFP-Kv1.2 and YFP-Kv1.2 were constructed by inserting the coding sequence of Kv1.2 into pECFP-C1 and pEYFP-C1, respectively, between BglII and SalI sites. Kv1.2HA was described previously (Gu et al., 2003) . EB1-YFP, EB1-CFP, and His-EB1 were constructed by inserting the coding sequence of EB1 into pEYFP-N1, pECFP-N1, and pRSET B, respectively, between BglII and HindIII. YFP-EB1N and YFP-EB1C were constructed by inserting EB1 cDNAs encoding residue 1-181 and 197-268 into pEYFP-C1, respectively, between BglII and HindIII. YFP-Kvb2C1, YFP-Kvb2C2, and YFP-Kvb2N were constructed by inserting Kvb2 cDNA encoding residue 1-353, 1-338, and 91-367 into pEYFP-C1, respectively, between EcoRI and SalI. Myc-EB1 was constructed by inserting the coding sequence of EB1 into pRK5 between SalI and NotI. CFP-VAMP2 was constructed by inserting the coding region of VAMP2 to pECFP-C1 between BglII and EcoRI.
KIF3A-GFP and KIF5-GFP was constructed by inserting the coding regions of KIF3A and KIF5 to pEGFP-N1 between EcoRI and SalI. These constructs were verified with restriction enzyme digestion and sequencing.
Structure-Based Mutagenesis
By employing the UCSF Chimera program, we designed two point mutations on Kvb2 at the Kvb2-T1 interface, M196A (Met at position 196 mutated to Ala) and K235E (Lys at position 235 mutated to Glu), used Quickchange strategy based upon the YFP-Kvb2 construct to generate the mutations, and verified them by sequencing.
Hippocampal Neuron Culture and Transfection
Hippocampal neuron culture was prepared as previously described (Gu et al., 2003) . In brief, 2 days after neuron plating, 1 mM cytosine arabinose was added to the neuronal culture medium to inhibit glial growth for the subsequent 2 days, then replaced with normal neuronal culture medium, replenished twice a week by replacing half with the fresh. For transient transfection, neurons in culture at 5 to 7 DIV were incubated in Opti-MEM containing 0.8 mg cDNA plasmid and 1.5 ml Lipofectamine 2000 (Invitrogen) for 30 min at 37 C.
Coimmunoprecipitation, Protein Purification and Western Blotting Rat brain or HEK293 cells transfected with various constructs were homogenized and solubilized in IP buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% Triton X100, and complete protease inhibitor tablet [Roche]) for 2 hr at 4 C, then centrifuged at 20,800 3 g for 30 min at 4 C. The supernatant was incubated (2-4 hr, 4 C) either with mouse anti-Kvb2 antibody and protein G agarose beads (Roche) or with rabbit anti-GFP antibody and protein A agarose beads (Invitrogen). The beads were washed six times with IP buffer and eluted with 23 sample buffer. The coimmunoprecipitates were resolved by SDS-PAGE, transferred to a PVDF membrane, and subjected to western blotting. The His-tagged EB1 (His-EB1) was expressed in BL21 cells induced by 1 mM IPTG for 4 hr at 37 C, solubilized in IP buffer with sonication at 4 C, centrifuged at 20,800 3 g for 30 min at 4 C, then purified with Talon Ni 2+ resin (Clontech). These resin beads coated with purified His-EB1 were either eluted with Imidazole-containing IP buffer or directly used for pull-down experiments with HEK293 cell lysates. Similarly, the GST-tagged Kvb2 (GSTKvb2) was purified with glutathione beads (Amersham) and incubated with rat brain lysates for pull-down of interacting proteins.
Immunocytochemistry and Fluorescence Microscopy As described previously (Gu et al., 2003) , neurons were permeabilized right after fixation for labeling the endogenous proteins and Kv1.2HA total proteins, whereas Kv1.2HA surface expression was revealed by labeling neurons with anti-HA antibody in nonpermeabilized condition after fixation. Fluorescence images were captured with Spot CCD camera RT slider (Diagnostic Instrument Inc.) in a Nikon upright microscope Eclipse E800 using Plan Apo objective 203/0.75, 603/1.4 oil, or 1003/1.4 oil, saved as 16-bit TIFF files, and analyzed with NIH Image J and Sigmaplot 8.0 for fluorescence intensity quantification. Exposure times were controlled so that the pixel intensities in dendrites and axons were below saturation, but the same exposure time was used within each group of experiment. Only transfected neurons with separated dendrites and axons and which were isolated from other transfected cells were chosen for analysis. The detailed quantification procedure is in Supplemental Data.
siRNA Suppression of Endogenous EB1 and KIF3A Expression in Neurons We used vector-based siRNA strategy to suppress the endogenous EB1 level in rat hippocampal neurons. Three 21 nucleotide sequences unique to rat EB1 were selected from the open reading frame, nucleotides 10-30 (EB1 siR1), nucleotides 62-82 (EB1 siR2), and nucleotides 221-241 (EB1 siR3). For constructing each siRNA construct, two complementary strands of DNA, from 5 0 to 3 0 , containing a BamH1 site, 21 nucleotide antisense, loop (TTGATATCCG), 21 nucleotide sense, and a HindIII site, were chemically synthesized and inserted into the BamHI/HindIII sites of pRNAT-H1.1/neo vector (GenScript), which also contains a GFP gene. EB1 siR2 (nucleotides 62-82, CAATGAATCTCTGCAGTTGAA) can efficiently suppress expression of EB1 in rat hippocampal neurons, as well as human EB1 with only one nucleotide difference in this region, while negative controls, one kindly provided by Dr. Z.H. Sheng and one scrambled EB1 siR2, had no effect on EB1 expression. The plasmids were usually transfected into hippocampal neurons with Lipofectamine 2000 (Invitrogen) at 4 DIV, and neurons were fixed and stained 3 days later. GFP fluorescence signal indicated the transfected neurons. As control, we cotransfected siRNA plasmids with EB1-GFP into HEK293 cells in 2:1 ratio. Three days later, the cells were lysed and resolved with SDS-PAGE and subsequentially blotted with anti-EB1, anti-a-tubulin, and anti-actin antibodies. The same strategy was used to generate KIF3A siRNA. From NCBI website, we found a cDNA sequence (accession number AF155825) containing the second half of rat KIF3A. Three siRNA probes were designed based upon this sequence. KIF3A siR2 (CAAGGAAAGACCAAGAAATTA) can efficiently suppress endogenous KIF3A level in rat neurons, while controls had no effect.
Live-Cell Time Lapse and FRET Imaging
Cultured neurons or HEK293 cells were plated onto 22 mm round glass coverslips (Fisher) and mounted to an imaging open chamber (Brook Industries) covered with Hank's buffer (20 mM HEPES [pH 7.2], 150 mM NaCl, 24 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10 mg/ml glucose). All experiments were performed in room temperature. The live-cell FRET imaging system consists an inverted microscope Nikon Eclipse 300, a black/white camera, SensiCam (The Cooke Corporation), and filter wheels (Sutter) with filters and controller LAMBDA 10-2 (Sutter) for both excitation and emission. Image captures and rapid switch of filters in both excitation and emission sides were achieved through Image-Pro Plus program (Media Cybernetics), allowing FRET measurement between CFP and YFP. For two-color time lapse imaging, only YFP and CFP filter channels were used. The bleedthrough across the YFP and CFP channels is less than 1% in our setup, and the fluorescence intensities of EB1-YFP and CFP-Kvb2 were similar, so the contribution of bleedthrough to our signals is minimal. For each series, 30 images were captured with 5 s interval. The CFP/YFP-positive particles moving anterogradely along axons were manually traced. The velocity of these moving particles was measured for a total of 85 particles from 18 neurons and then averaged. The strategy and protocol of FRET imaging were described previously (Gu et al., 2001; Sorkin et al., 2000) . In brief, three images were acquired sequentially through (1) CFP filter set (excitation 430/25 nm, emission 470/30 nm); (2) YFP filter set (excitation 500/20 nm, emission 535/30 nm); (3) FRET filter set (excitation 430/25 nm, emission 535/30 nm). A single dichroic mirror (86004BS; Chroma) was used with all three filter channels. FRET between CFP and YFP was measured and calculated for the entire image on a pixel-by-pixel basis by a three-filter ''microFRET'' method. The raw FRET images consisted of both FRET and non-FRET components (the donor and acceptor fluorescence bleeding through the FRET filter). The extent of crossbleeding was characteristic of the particular optical system and determined by the use of cells that express either CFP or YFP alone. In our system, 60.3% 6 1.5% (n = 6) of CFP, and 23.6% 6 0.8% (n = 6) of YFP fluorescence can bleed through the FRET channel. Therefore, to ensure our images contain no bleedthrough components, we subtracted the raw FRET image with CFP image multiplied by 0.65 and YFP image multiplied by 0.25. All calculations for images were performed after subtraction of the background fluorescence values.
TIRF Imaging
TIRF imaging was done using a Nikon TE-2000E inverted microscope with a 603 1.45 NA TIRF objective (Nikon), equipped for through-the-objective TIRF microscopy. A 488 nm Argon-ion laser (Melles Griot) and a 543 nm HeNe laser (Spectra Physics) were used as light sources. The laser output was transmitted through a fiber optic cable, the position of which was adjusted using a micrometer to focus the beam off-axis at the back focal plane at an angle greater than 61 to generate the evanescent wave. Images were acquired using a C9100-12 EM-CCD camera (Hamamatsu Photonics) driven by IPLab (Scanalytics).
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/52/5/803/DC1/.
